Overall, we gained important insight into the spatial requirements for a functional interaction between TRAIL and DR5 at the plasma membrane, not only for the informed design of improved TR3-based cancer drugs but also with regard to the biology of a native and representative member of the large TNF superfamily. This evidence concerns the gene TNFSF10 and cancer.